Related Experiment Video
Updated: May 7, 2026

Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model
Published on: August 29, 2012
Medin induces pro-inflammatory activation of human brain vascular smooth muscle cells
Nina Karamanova1, Kaleb T Morrow1, Alana Maerivoet2
1Phoenix Veterans Affairs Health Care System, Phoenix, Arizona, USA.
Abstract:
Medin, a common amyloidogenic protein, accumulates in the vasculature with aging. We evaluated the effects of medin on human brain vascular smooth muscle cell (VSMC) activation. VSMCs were exposed to medin (0.5, 1, and 5 μM) without or with the small molecule nuclear factor-κB (NFκB) inhibitor RO106-9920 (10 μM). Polymerase chain reaction, Western blot/enzyme-linked immunosorbent assays were used to quantify gene and protein expressions/secretions, respectively, of pro-inflammatory factors (interleukin (IL)-6, IL-8, and monocyte chemoattractant protein (MCP)-1) and structural and enzyme proteins associated with VSMC phenotypic transformation (smooth muscle actin alpha 2 (ACTA2), myosin heavy chain 11 (MYH11) and NADPH oxidase 4 (NOX4)). Medin increased VSMC gene expression and protein secretion of IL-6, IL-8, and MCP-1 (protein secretion 46.0 ± 12.8x, 20.2 ± 4.1x, and 8.7 ± 3.1x, respectively, medin 5 μM versus vehicle, p < 0.05). There was no change in gene/protein expressions of ACTA2, MYH11, and NOX4. Co-treatment with RO106-9920 reduced medin-induced increases in IL-6 and IL-8 with a trend towards reduced MCP-1 secretion. Medin induced pro-inflammatory activation of human brain VSMCs that is mediated in part by NFκB. Acute medin treatment did not alter structural proteins involved in VSMC phenotypic transformation. The findings support medin as a potential novel mediator of and therapeutic target for vascular aging pathology.
Insights
Medin protein accumulation in blood vessels with aging promotes inflammation in human brain vascular smooth muscle cells (VSMCs). Inhibiting nuclear factor-κB (NFκB) partially reduces this medin-induced inflammation, suggesting medin as a therapeutic target for vascular aging.
Area of Science:
- Vascular Biology
- Aging Research
- Cellular Inflammation
Background:
- Medin is an amyloidogenic protein that accumulates in vasculature with aging.
- Vascular smooth muscle cell (VSMC) activation contributes to vascular aging pathology.
Purpose of the Study:
- To investigate the effects of medin on human brain VSMC activation.
- To determine the role of nuclear factor-κB (NFκB) in medin-induced VSMC pro-inflammatory responses.
Main Methods:
- VSMCs were treated with medin (0.5, 1, 5 μM) with or without an NFκB inhibitor (RO106-9920).
- Gene and protein expression/secretion of inflammatory factors (IL-6, IL-8, MCP-1) and VSMC markers (ACTA2, MYH11, NOX4) were quantified using PCR and ELISA/Western blot.
Main Results:
- Medin significantly increased VSMC gene expression and protein secretion of IL-6, IL-8, and MCP-1.
- NFκB inhibition partially reduced medin-induced IL-6 and IL-8 secretion, with a trend for MCP-1.
- Medin did not alter the expression of ACTA2, MYH11, or NOX4, indicating no effect on VSMC phenotypic transformation.
Conclusions:
- Medin induces pro-inflammatory activation of human brain VSMCs.
- This activation is partially mediated by the NFκB pathway.
- Medin is a potential therapeutic target for mitigating vascular aging pathology.
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Acute Inflammation II: Local and Systemic Effects
Bacterial Meningitis II: Pathophysiology

